Home / Contract Awards / Leidos to Help USAID Facilitate Malaria Vaccine R&D Projects; Jerry Hogge Comments

Leidos to Help USAID Facilitate Malaria Vaccine R&D Projects; Jerry Hogge Comments

LeidosLogoLeidos (NYSE: LDOS) has been awarded a potential five-year, $23.7 million contract to support the U.S. Agency for International Development‘s efforts to research and develop a vaccine against malaria.

The company said Monday it will provide scientific and management services for USAID’s Malaria Vaccine Development Program under the cost-plus-fixed-fee contract.

Jerry Hogge, Leidos health deputy group president, said the company brings decades of life sciences technology and experience to the USAID program.

Leidos said the work to occur in Frederick, Maryland, could also evaluate malaria vaccine candidates during preclinical studies and clinical and field trials.

The company’s life sciences team supports medical product R&D efforts at the National Institutes of Health and the departments of Defense and Homeland Security.

Check Also

DARPA Taps Northrop, Raytheon, Collins Aerospace to Develop Counter-A2/AD Platforms

Northrop Grumman (NYSE: NOC), Raytheon (NYSE: RTN) and Collins Aerospace has landed contracts from the Defense Advanced Research Projects Agency to develop technology platforms for countering anti-access/area denial threats. DARPA selected the three companies to participate in the first and second phases of the System-of -Systems Enhanced Small Unit program, according to a notice posted Tuesday on the beta SAM website.

Liberty IT Wins $380M Task Order to Develop VA API Platform

Liberty IT Solutions has secured a $380M task order to help the Department of Veterans Affairs develop and manage an application programming interface platform.